Krystal Biotech, Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Pittsburgh PA United States (2015)

Organization Overview

First Clinical Trial
2018
NCT03536143
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Krystal Biotech, Inc.